Global and United States Vero Cell Rabies Vaccines for Human Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Market Analysis and Insights: Global and United States Vero Cell Rabies Vaccines for Human Market
This report focuses on global and United States Vero Cell Rabies Vaccines for Human market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Vero Cell Rabies Vaccines for Human market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Freeze-dried Powder accounting for % of the Vero Cell Rabies Vaccines for Human global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Pre-exposure Prophylaxis was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Vero Cell Rabies Vaccines for Human market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Vero Cell Rabies Vaccines for Human Scope and Market Size
Vero Cell Rabies Vaccines for Human market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Vero Cell Rabies Vaccines for Human market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Vero Cell Rabies Vaccines for Human market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Freeze-dried Powder
    Liquid

Segment by Application
    Pre-exposure Prophylaxis
    Post-exposure Prophylaxis

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Bharat Biotech
    Sanofi-Pasteur
    Chengda Bio
    Prcmise
    Zhuoyi Biological
    Ningbo Rongan Biological
    Indian Immunologicals

 1 Study Coverage
    1.1 Vero Cell Rabies Vaccines for Human Product Introduction
    1.2 Global Vero Cell Rabies Vaccines for Human Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Vero Cell Rabies Vaccines for Human Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Vero Cell Rabies Vaccines for Human Sales in Volume for the Year 2017-2028
    1.3 United States Vero Cell Rabies Vaccines for Human Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Vero Cell Rabies Vaccines for Human Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Vero Cell Rabies Vaccines for Human Sales in Volume for the Year 2017-2028
    1.4 Vero Cell Rabies Vaccines for Human Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Vero Cell Rabies Vaccines for Human in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Vero Cell Rabies Vaccines for Human Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Vero Cell Rabies Vaccines for Human Market Dynamics
        1.5.1 Vero Cell Rabies Vaccines for Human Industry Trends
        1.5.2 Vero Cell Rabies Vaccines for Human Market Drivers
        1.5.3 Vero Cell Rabies Vaccines for Human Market Challenges
        1.5.4 Vero Cell Rabies Vaccines for Human Market Restraints
    1.6 Study Objectives
    1.7 Years Considered

 2 Market by Type
    2.1 Vero Cell Rabies Vaccines for Human Market Segment by Type
        2.1.1 Freeze-dried Powder
        2.1.2 Liquid
    2.2 Global Vero Cell Rabies Vaccines for Human Market Size by Type
        2.2.1 Global Vero Cell Rabies Vaccines for Human Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Vero Cell Rabies Vaccines for Human Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Vero Cell Rabies Vaccines for Human Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Vero Cell Rabies Vaccines for Human Market Size by Type
        2.3.1 United States Vero Cell Rabies Vaccines for Human Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Vero Cell Rabies Vaccines for Human Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Vero Cell Rabies Vaccines for Human Average Selling Price (ASP) by Type (2017, 2022 & 2028)

 3 Market by Application
    3.1 Vero Cell Rabies Vaccines for Human Market Segment by Application
        3.1.1 Pre-exposure Prophylaxis
        3.1.2 Post-exposure Prophylaxis
    3.2 Global Vero Cell Rabies Vaccines for Human Market Size by Application
        3.2.1 Global Vero Cell Rabies Vaccines for Human Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Vero Cell Rabies Vaccines for Human Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Vero Cell Rabies Vaccines for Human Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Vero Cell Rabies Vaccines for Human Market Size by Application
        3.3.1 United States Vero Cell Rabies Vaccines for Human Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Vero Cell Rabies Vaccines for Human Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Vero Cell Rabies Vaccines for Human Average Selling Price (ASP) by Application (2017, 2022 & 2028)

 4 Global Vero Cell Rabies Vaccines for Human Competitor Landscape by Company
    4.1 Global Vero Cell Rabies Vaccines for Human Market Size by Company
        4.1.1 Top Global Vero Cell Rabies Vaccines for Human Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Vero Cell Rabies Vaccines for Human Revenue by Manufacturer (2017-2022)
        4.1.3 Global Vero Cell Rabies Vaccines for Human Sales by Manufacturer (2017-2022)
        4.1.4 Global Vero Cell Rabies Vaccines for Human Price by Manufacturer (2017-2022)
    4.2 Global Vero Cell Rabies Vaccines for Human Concentration Ratio (CR)
        4.2.1 Vero Cell Rabies Vaccines for Human Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Vero Cell Rabies Vaccines for Human in 2021
        4.2.3 Global Vero Cell Rabies Vaccines for Human Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Vero Cell Rabies Vaccines for Human Manufacturing Base Distribution, Product Type
        4.3.1 Global Vero Cell Rabies Vaccines for Human Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Vero Cell Rabies Vaccines for Human Product Type
        4.3.3 Date of International Manufacturers Enter into Vero Cell Rabies Vaccines for Human Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Vero Cell Rabies Vaccines for Human Market Size by Company
        4.5.1 Top Vero Cell Rabies Vaccines for Human Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Vero Cell Rabies Vaccines for Human Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Vero Cell Rabies Vaccines for Human Sales by Players (2020, 2021 & 2022)

 5 Global Vero Cell Rabies Vaccines for Human Market Size by Region
    5.1 Global Vero Cell Rabies Vaccines for Human Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Vero Cell Rabies Vaccines for Human Market Size in Volume by Region (2017-2028)
        5.2.1 Global Vero Cell Rabies Vaccines for Human Sales in Volume by Region: 2017-2022
        5.2.2 Global Vero Cell Rabies Vaccines for Human Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Vero Cell Rabies Vaccines for Human Market Size in Value by Region (2017-2028)
        5.3.1 Global Vero Cell Rabies Vaccines for Human Sales in Value by Region: 2017-2022
        5.3.2 Global Vero Cell Rabies Vaccines for Human Sales in Value by Region: 2023-2028

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Vero Cell Rabies Vaccines for Human Market Size YoY Growth 2017-2028
        6.1.2 North America Vero Cell Rabies Vaccines for Human Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Vero Cell Rabies Vaccines for Human Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Vero Cell Rabies Vaccines for Human Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Vero Cell Rabies Vaccines for Human Market Size YoY Growth 2017-2028
        6.3.2 Europe Vero Cell Rabies Vaccines for Human Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Vero Cell Rabies Vaccines for Human Market Size YoY Growth 2017-2028
        6.4.2 Latin America Vero Cell Rabies Vaccines for Human Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
        6.4.6 Colombia
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Vero Cell Rabies Vaccines for Human Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Vero Cell Rabies Vaccines for Human Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Bharat Biotech
        7.1.1 Bharat Biotech Corporation Information
        7.1.2 Bharat Biotech Description and Business Overview
        7.1.3 Bharat Biotech Vero Cell Rabies Vaccines for Human Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Bharat Biotech Vero Cell Rabies Vaccines for Human Products Offered
        7.1.5 Bharat Biotech Recent Development
    7.2 Sanofi-Pasteur
        7.2.1 Sanofi-Pasteur Corporation Information
        7.2.2 Sanofi-Pasteur Description and Business Overview
        7.2.3 Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Products Offered
        7.2.5 Sanofi-Pasteur Recent Development
    7.3 Chengda Bio
        7.3.1 Chengda Bio Corporation Information
        7.3.2 Chengda Bio Description and Business Overview
        7.3.3 Chengda Bio Vero Cell Rabies Vaccines for Human Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Chengda Bio Vero Cell Rabies Vaccines for Human Products Offered
        7.3.5 Chengda Bio Recent Development
    7.4 Prcmise
        7.4.1 Prcmise Corporation Information
        7.4.2 Prcmise Description and Business Overview
        7.4.3 Prcmise Vero Cell Rabies Vaccines for Human Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Prcmise Vero Cell Rabies Vaccines for Human Products Offered
        7.4.5 Prcmise Recent Development
    7.5 Zhuoyi Biological
        7.5.1 Zhuoyi Biological Corporation Information
        7.5.2 Zhuoyi Biological Description and Business Overview
        7.5.3 Zhuoyi Biological Vero Cell Rabies Vaccines for Human Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Zhuoyi Biological Vero Cell Rabies Vaccines for Human Products Offered
        7.5.5 Zhuoyi Biological Recent Development
    7.6 Ningbo Rongan Biological
        7.6.1 Ningbo Rongan Biological Corporation Information
        7.6.2 Ningbo Rongan Biological Description and Business Overview
        7.6.3 Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Products Offered
        7.6.5 Ningbo Rongan Biological Recent Development
    7.7 Indian Immunologicals
        7.7.1 Indian Immunologicals Corporation Information
        7.7.2 Indian Immunologicals Description and Business Overview
        7.7.3 Indian Immunologicals Vero Cell Rabies Vaccines for Human Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Indian Immunologicals Vero Cell Rabies Vaccines for Human Products Offered
        7.7.5 Indian Immunologicals Recent Development

 8 Industry Chain and Sales Channels Analysis
    8.1 Vero Cell Rabies Vaccines for Human Industry Chain Analysis
    8.2 Vero Cell Rabies Vaccines for Human Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Vero Cell Rabies Vaccines for Human Distributors
    8.3 Vero Cell Rabies Vaccines for Human Production Mode & Process
    8.4 Vero Cell Rabies Vaccines for Human Sales and Marketing
        8.4.1 Vero Cell Rabies Vaccines for Human Sales Channels
        8.4.2 Vero Cell Rabies Vaccines for Human Distributors
    8.5 Vero Cell Rabies Vaccines for Human Customers

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Vero Cell Rabies Vaccines for Human CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Vero Cell Rabies Vaccines for Human Market Trends
    Table 3. Vero Cell Rabies Vaccines for Human Market Drivers
    Table 4. Vero Cell Rabies Vaccines for Human Market Challenges
    Table 5. Vero Cell Rabies Vaccines for Human Market Restraints
    Table 6. Global Vero Cell Rabies Vaccines for Human Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Vero Cell Rabies Vaccines for Human Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Vero Cell Rabies Vaccines for Human Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Vero Cell Rabies Vaccines for Human Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Vero Cell Rabies Vaccines for Human Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Vero Cell Rabies Vaccines for Human Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Vero Cell Rabies Vaccines for Human Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Vero Cell Rabies Vaccines for Human Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Vero Cell Rabies Vaccines for Human Sales Share by Manufacturer, 2017-2022
    Table 15. Global Vero Cell Rabies Vaccines for Human Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Vero Cell Rabies Vaccines for Human Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Vero Cell Rabies Vaccines for Human by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vero Cell Rabies Vaccines for Human as of 2021)
    Table 18. Top Players of Vero Cell Rabies Vaccines for Human in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Vero Cell Rabies Vaccines for Human Product Type
    Table 20. Date of International Manufacturers Enter into Vero Cell Rabies Vaccines for Human Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Vero Cell Rabies Vaccines for Human Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Vero Cell Rabies Vaccines for Human Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Vero Cell Rabies Vaccines for Human Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Vero Cell Rabies Vaccines for Human Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Vero Cell Rabies Vaccines for Human Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Vero Cell Rabies Vaccines for Human Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Vero Cell Rabies Vaccines for Human Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Vero Cell Rabies Vaccines for Human Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Vero Cell Rabies Vaccines for Human Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Vero Cell Rabies Vaccines for Human Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Vero Cell Rabies Vaccines for Human Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Vero Cell Rabies Vaccines for Human Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Vero Cell Rabies Vaccines for Human Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Vero Cell Rabies Vaccines for Human Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Vero Cell Rabies Vaccines for Human Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Vero Cell Rabies Vaccines for Human Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Vero Cell Rabies Vaccines for Human Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Vero Cell Rabies Vaccines for Human Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Bharat Biotech Corporation Information
    Table 43. Bharat Biotech Description and Business Overview
    Table 44. Bharat Biotech Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Bharat Biotech Vero Cell Rabies Vaccines for Human Product
    Table 46. Bharat Biotech Recent Development
    Table 47. Sanofi-Pasteur Corporation Information
    Table 48. Sanofi-Pasteur Description and Business Overview
    Table 49. Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Sanofi-Pasteur Product
    Table 51. Sanofi-Pasteur Recent Development
    Table 52. Chengda Bio Corporation Information
    Table 53. Chengda Bio Description and Business Overview
    Table 54. Chengda Bio Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Chengda Bio Product
    Table 56. Chengda Bio Recent Development
    Table 57. Prcmise Corporation Information
    Table 58. Prcmise Description and Business Overview
    Table 59. Prcmise Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Prcmise Product
    Table 61. Prcmise Recent Development
    Table 62. Zhuoyi Biological Corporation Information
    Table 63. Zhuoyi Biological Description and Business Overview
    Table 64. Zhuoyi Biological Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Zhuoyi Biological Product
    Table 66. Zhuoyi Biological Recent Development
    Table 67. Ningbo Rongan Biological Corporation Information
    Table 68. Ningbo Rongan Biological Description and Business Overview
    Table 69. Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Ningbo Rongan Biological Product
    Table 71. Ningbo Rongan Biological Recent Development
    Table 72. Indian Immunologicals Corporation Information
    Table 73. Indian Immunologicals Description and Business Overview
    Table 74. Indian Immunologicals Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Indian Immunologicals Product
    Table 76. Indian Immunologicals Recent Development
    Table 77. Key Raw Materials Lists
    Table 78. Raw Materials Key Suppliers Lists
    Table 79. Vero Cell Rabies Vaccines for Human Customers List
    Table 80. Vero Cell Rabies Vaccines for Human Distributors List
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. Vero Cell Rabies Vaccines for Human Product Picture
    Figure 2. Global Vero Cell Rabies Vaccines for Human Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Vero Cell Rabies Vaccines for Human Market Size 2017-2028 (US$ Million)
    Figure 4. Global Vero Cell Rabies Vaccines for Human Sales 2017-2028 (K Units)
    Figure 5. United States Vero Cell Rabies Vaccines for Human Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Vero Cell Rabies Vaccines for Human Market Size 2017-2028 (US$ Million)
    Figure 7. United States Vero Cell Rabies Vaccines for Human Sales 2017-2028 (K Units)
    Figure 8. United States Vero Cell Rabies Vaccines for Human Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Vero Cell Rabies Vaccines for Human Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Vero Cell Rabies Vaccines for Human Report Years Considered
    Figure 11. Product Picture of Freeze-dried Powder
    Figure 12. Product Picture of Liquid
    Figure 13. Global Vero Cell Rabies Vaccines for Human Market Share by Type in 2022 & 2028
    Figure 14. Global Vero Cell Rabies Vaccines for Human Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Vero Cell Rabies Vaccines for Human Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Vero Cell Rabies Vaccines for Human Price by Type (2017-2028) & (US$/Unit)
    Figure 19. United States Vero Cell Rabies Vaccines for Human Market Share by Type in 2022 & 2028
    Figure 20. United States Vero Cell Rabies Vaccines for Human Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Vero Cell Rabies Vaccines for Human Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Vero Cell Rabies Vaccines for Human Price by Type (2017-2028) & (US$/Unit)
    Figure 25. Product Picture of Pre-exposure Prophylaxis
    Figure 26. Product Picture of Post-exposure Prophylaxis
    Figure 27. Global Vero Cell Rabies Vaccines for Human Market Share by Application in 2022 & 2028
    Figure 28. Global Vero Cell Rabies Vaccines for Human Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global Vero Cell Rabies Vaccines for Human Sales by Application (2017-2028) & (K Units)
    Figure 31. Global Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global Vero Cell Rabies Vaccines for Human Price by Application (2017-2028) & (US$/Unit)
    Figure 33. United States Vero Cell Rabies Vaccines for Human Market Share by Application in 2022 & 2028
    Figure 34. United States Vero Cell Rabies Vaccines for Human Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States Vero Cell Rabies Vaccines for Human Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States Vero Cell Rabies Vaccines for Human Sales by Application (2017-2028) & (K Units)
    Figure 37. United States Vero Cell Rabies Vaccines for Human Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States Vero Cell Rabies Vaccines for Human Price by Application (2017-2028) & (US$/Unit)
    Figure 39. North America Vero Cell Rabies Vaccines for Human Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 40. North America Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. United States Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Europe Vero Cell Rabies Vaccines for Human Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. Europe Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. Germany Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. France Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. U.K. Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Italy Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Russia Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 51. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. China Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Japan Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. South Korea Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. India Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Australia Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. China Taiwan Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Latin America Vero Cell Rabies Vaccines for Human Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 62. Latin America Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 63. Mexico Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Brazil Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Argentina Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Colombia Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 68. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. UAE Vero Cell Rabies Vaccines for Human Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Vero Cell Rabies Vaccines for Human Value Chain
    Figure 73. Vero Cell Rabies Vaccines for Human Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed

Market Analysis and Insights: Global and United States Vero Cell Rabies Vaccines for Human Market
This report focuses on global and United States Vero Cell Rabies Vaccines for Human market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Vero Cell Rabies Vaccines for Human market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Freeze-dried Powder accounting for % of the Vero Cell Rabies Vaccines for Human global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Pre-exposure Prophylaxis was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Vero Cell Rabies Vaccines for Human market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Vero Cell Rabies Vaccines for Human Scope and Market Size
Vero Cell Rabies Vaccines for Human market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Vero Cell Rabies Vaccines for Human market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Vero Cell Rabies Vaccines for Human market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Freeze-dried Powder
    Liquid

Segment by Application
    Pre-exposure Prophylaxis
    Post-exposure Prophylaxis

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Bharat Biotech
    Sanofi-Pasteur
    Chengda Bio
    Prcmise
    Zhuoyi Biological
    Ningbo Rongan Biological
    Indian Immunologicals